| Home > Publications Database > Sex differences in treatment effects of lecanemab and donanemab: A Bayesian reanalysis of CLARITY-AD and TRAILBLAZER-ALZ2. > Access to Fulltext |
DZNE-2025-01084
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||||||||
DZNE-2025-01084 SUP1
|
|||||||||||||
| version 1 |
| ||||||||||||
| Restricted | |||||||
DZNE-2025-01084 SUP2
|
|||||||
| version 1 |
| ||||||